Senzime AB (publ) SNZZF
0.24 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.2609 Day range 0.2609
0.2352 52-week range 0.65
- YTD
- -56.61%
- 1 year
- -63.82%
- Market cap
- 46.32M
- EPS (ttm)
- -0.07
- YTD return
- -56.61%
- 1-year return
- -63.82%
- Volume
- 2.50K
- Avg volume
- 9.77K
- Open
- 0.2609
- Previous close
- 0.2352
- Day's range
- 0.2609 – 0.2609
- 52-week range
- 0.2352 – 0.65
2Y -0.3548 (-60.14%)
News
Senzime AB (publ) (SNZZF) Q3 2026 Earnings Call Transcript 
Senzime AB (publ) (SNZZF) Q3 2026 Earnings Call Prepared Remarks Transcript 
New Scientific Evidence Presented at ANESTHESIOLOGY 2026 Strengthens the Case for Senzime's TetraGraph and Quantitative Neuromuscular Monitoring 
Senzime Launches Industry-First Predictive Neuromuscular Monitoring Technology 
Senzime Reaffirms Its Target of Reaching Positive Cash Flow Within Q4 2026 
Senzime AB (publ) (SNZZF) Discusses Market Update, Philips Partnership, OEM Business Insights and Financing Package Transcript 
Senzime Strengthens Financing to Support Strategic OEM Expansion and Path to Profitability 
Senzime Secures Additional Major US Hospital Network Contract, Expanding Adoption of its Next-generation Neuromuscular Monitoring Technology 
Senzime Awarded Exclusive 5-Year National Supply Contract with U.S. Veterans Affairs Through Its Partner TrillaMed 
Senzime AB (publ) (SNZZF) Q2 2026 Earnings Call Transcript
Your note
Sign in to keep a note on SNZZF — it syncs with the Stock Master app.